 | • レポートコード：GIR-105X06193 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エロツズマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エロツズマブの種類別市場規模（300mg注射、400mg注射）、用途別市場規模（病院、クリニック、ドラッグセンター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エロツズマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bristol Myers Squibb、Abbvie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：300mg注射、400mg注射 ・用途別分析2016年-2026年：病院、クリニック、ドラッグセンター、その他 ・エロツズマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エロツズマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エロツズマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エロツズマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エロツズマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Elotuzumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Elotuzumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Elotuzumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Elotuzumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
300mg Injection
400mg Injection
Market segment by Application can be divided into
Hospital
Clinic
Drug Center
Other
The key market players for global Elotuzumab market are listed below:
Bristol Myers Squibb
Abbvie
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Elotuzumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Elotuzumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 300mg Injection
1.2.3 400mg Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Elotuzumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Elotuzumab Market Size & Forecast
1.4.1 Global Elotuzumab Sales in Value (2016-2026))
1.4.2 Global Elotuzumab Sales in Volume (2016-2026)
1.4.3 Global Elotuzumab Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Elotuzumab Production Capacity Analysis
1.5.1 Global Elotuzumab Total Production Capacity (2016-2026)
1.5.2 Global Elotuzumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Elotuzumab Market Drivers
1.6.2 Elotuzumab Market Restraints
1.6.3 Elotuzumab Trends Analysis
2 Manufacturers Profiles
2.1 Bristol Myers Squibb
2.1.1 Bristol Myers Squibb Details
2.1.2 Bristol Myers Squibb Major Business
2.1.3 Bristol Myers Squibb Elotuzumab Product and Services
2.1.4 Bristol Myers Squibb Elotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Abbvie
2.2.1 Abbvie Details
2.2.2 Abbvie Major Business
2.2.3 Abbvie Elotuzumab Product and Services
2.2.4 Abbvie Elotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Elotuzumab Sales by Manufacturer
3.1 Global Elotuzumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Elotuzumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Elotuzumab
3.4 Market Concentration Rate
3.4.1 Top 3 Elotuzumab Manufacturer Market Share
3.4.2 Top 6 Elotuzumab Manufacturer Market Share
3.5 Global Elotuzumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Elotuzumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Elotuzumab Market Size by Region
4.1.1 Global Elotuzumab Sales in Volume by Region (2016-2026)
4.1.2 Global Elotuzumab Revenue by Region (2016-2026)
4.2 North America Elotuzumab Revenue (2016-2026)
4.3 Europe Elotuzumab Revenue (2016-2026)
4.4 Asia-Pacific Elotuzumab Revenue (2016-2026)
4.5 South America Elotuzumab Revenue (2016-2026)
4.6 Middle East and Africa Elotuzumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Elotuzumab Sales in Volume by Type (2016-2026)
5.2 Global Elotuzumab Revenue by Type (2016-2026)
5.3 Global Elotuzumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Elotuzumab Sales in Volume by Application (2016-2026)
6.2 Global Elotuzumab Revenue by Application (2016-2026)
6.3 Global Elotuzumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Elotuzumab Sales by Type (2016-2026)
7.2 North America Elotuzumab Sales by Application (2016-2026)
7.3 North America Elotuzumab Market Size by Country
7.3.1 North America Elotuzumab Sales in Volume by Country (2016-2026)
7.3.2 North America Elotuzumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Elotuzumab Sales by Type (2016-2026)
8.2 Europe Elotuzumab Sales by Application (2016-2026)
8.3 Europe Elotuzumab Market Size by Country
8.3.1 Europe Elotuzumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Elotuzumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Elotuzumab Sales by Type (2016-2026)
9.2 Asia-Pacific Elotuzumab Sales by Application (2016-2026)
9.3 Asia-Pacific Elotuzumab Market Size by Region
9.3.1 Asia-Pacific Elotuzumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Elotuzumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Elotuzumab Sales by Type (2016-2026)
10.2 South America Elotuzumab Sales by Application (2016-2026)
10.3 South America Elotuzumab Market Size by Country
10.3.1 South America Elotuzumab Sales in Volume by Country (2016-2026)
10.3.2 South America Elotuzumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Elotuzumab Sales by Type (2016-2026)
11.2 Middle East & Africa Elotuzumab Sales by Application (2016-2026)
11.3 Middle East & Africa Elotuzumab Market Size by Country
11.3.1 Middle East & Africa Elotuzumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Elotuzumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Elotuzumab Typical Distributors
12.3 Elotuzumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Elotuzumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Elotuzumab Revenue by Application, (USD Million), 2021-2026
Table 3. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol Myers Squibb Major Business
Table 5. Bristol Myers Squibb Elotuzumab Product and Services
Table 6. Bristol Myers Squibb Elotuzumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbvie Basic Information, Manufacturing Base and Competitors
Table 8. Abbvie Major Business
Table 9. Abbvie Elotuzumab Product and Services
Table 10. Abbvie Elotuzumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Elotuzumab Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Elotuzumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Elotuzumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Elotuzumab Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Elotuzumab Production Site of Key Manufacturer
Table 16. Global Elotuzumab Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Elotuzumab Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Elotuzumab Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Elotuzumab Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Elotuzumab Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Elotuzumab Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Elotuzumab Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Elotuzumab Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Elotuzumab Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Elotuzumab Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Elotuzumab Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Elotuzumab Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Elotuzumab Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Elotuzumab Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Elotuzumab Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Elotuzumab Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Elotuzumab Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Elotuzumab Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Elotuzumab Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Elotuzumab Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Elotuzumab Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Elotuzumab Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Elotuzumab Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Elotuzumab Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Elotuzumab Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Elotuzumab Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Elotuzumab Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Elotuzumab Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Elotuzumab Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Elotuzumab Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Elotuzumab Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Elotuzumab Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Elotuzumab Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Elotuzumab Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Elotuzumab Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Elotuzumab Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Elotuzumab Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Elotuzumab Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Elotuzumab Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Elotuzumab Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Elotuzumab Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Elotuzumab Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Elotuzumab Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Elotuzumab Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Elotuzumab Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Elotuzumab Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Elotuzumab Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Elotuzumab Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Elotuzumab Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Elotuzumab Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Elotuzumab Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Elotuzumab Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Elotuzumab Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Elotuzumab Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Elotuzumab Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Elotuzumab Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Elotuzumab Typical Distributors
Table 75. Elotuzumab Typical Customers
List of Figures
Figure 1. Elotuzumab Picture
Figure 2. Global Elotuzumab Sales Market Share by Type in 2020
Figure 3. 300mg Injection
Figure 4. 400mg Injection
Figure 5. Global Elotuzumab Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Drug Center
Figure 9. Other
Figure 10. Global Elotuzumab Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Elotuzumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Elotuzumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Elotuzumab Sales (2016-2026) & (K Pcs)
Figure 32. Global Elotuzumab Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Elotuzumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Elotuzumab Market Drivers
Figure 35. Elotuzumab Market Restraints
Figure 36. Elotuzumab Market Trends
Figure 37. Global Elotuzumab Sales Market Share by Manufacturer in 2020
Figure 38. Global Elotuzumab Revenue Market Share by Manufacturer in 2020
Figure 39. Elotuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Elotuzumab Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Elotuzumab Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Elotuzumab Sales Market Share by Region (2016-2026)
Figure 43. Global Elotuzumab Revenue Market Share by Region (2016-2026)
Figure 44. North America Elotuzumab Revenue (2016-2026) & (USD Million)
Figure 45. Europe Elotuzumab Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Elotuzumab Revenue (2016-2026) & (USD Million)
Figure 47. South America Elotuzumab Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Elotuzumab Revenue (2016-2026) & (USD Million)
Figure 49. Global Elotuzumab Sales Market Share by Type (2016-2026)
Figure 50. Global Elotuzumab Revenue Market Share by Type (2016-2026)
Figure 51. Global Elotuzumab Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Elotuzumab Sales Market Share by Application (2016-2026)
Figure 53. Global Elotuzumab Revenue Market Share by Application (2016-2026)
Figure 54. Global Elotuzumab Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Elotuzumab Sales Market Share by Country (2016-2026)
Figure 56. North America Elotuzumab Revenue Market Share by Country (2016-2026)
Figure 57. North America Elotuzumab Sales Market Share by Type (2016-2026)
Figure 58. North America Elotuzumab Sales Market Share by Application (2016-2026)
Figure 59. Europe Elotuzumab Sales Market Share by Country (2016-2026)
Figure 60. Europe Elotuzumab Revenue Market Share by Country (2016-2026)
Figure 61. Europe Elotuzumab Sales Market Share by Type (2016-2026)
Figure 62. Europe Elotuzumab Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Elotuzumab Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Elotuzumab Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Elotuzumab Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Elotuzumab Sales Market Share by Application (2016-2026)
Figure 67. South America Elotuzumab Sales Market Share by Country (2016-2026)
Figure 68. South America Elotuzumab Revenue Market Share by Country (2016-2026)
Figure 69. South America Elotuzumab Sales Market Share by Type (2016-2026)
Figure 70. South America Elotuzumab Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Elotuzumab Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Elotuzumab Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Elotuzumab Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Elotuzumab Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の注射用ウロキナーゼ市場 2021：企業別、地域別、種類・用途別 The Urokinase for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- 世界のマンニトール注射市場 2021：企業別、地域別、種類・用途別 The Mannitol Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の皮下注射免疫グロブリン市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Injection Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界のパパベリン塩酸塩注射市場 2021：企業別、地域別、種類・用途別 The Papaverine Hydrochloride Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のベリムマブ市場 2021：企業別、地域別、種類・用途別 The Belimumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent d…